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replication or nuclease-dependent degradation. This short-
ening is counteracted by a specialized reverse transcriptase 
called telomerase (Greider and Blackburn 1985). The conse-
quences of improper telomere length regulation are severe: 
several human diseases are linked to telomere shortening 
(reviewed in Blasco 2005; Armanios and Blackburn 2012), 
and upregulation of telomerase is a common feature in can-
cer cells (Kim et al. 1994).
Telomere length homeostasis maintenance is a tightly 
regulated process and has been best studied in the bud-
ding yeast Saccharomyces cerevisiae, whose telomeres 
consist of 300 ± 75 bp of  C1–3A/TG1–3 repeats (Wellinger 
and Zakian 2012). Not all telomeres are elongated during 
each cell cycle and the probability of extension of a given 
telomere is inversely correlated to its length, with shorter 
telomeres preferentially elongated (Teixeira et al. 2004). In 
budding yeast, the double-stranded telomeric DNA-binding 
protein Rap1 forms a complex together with Rif1 and Rif2 
to negatively regulate telomerase (Wotton and Shore 1997). 
According to the protein-counting model (Marcand et al. 
1997), telomere-bound Rap1 increases proportionally with 
telomere length, preventing telomerase from extending the 
longer telomeres, thereby providing a mechanism to main-
tain telomere length homeostasis.
The evolutionarily conserved Pif1 helicase is also an 
important player in telomere length regulation. In vitro, 
Pif1 reduces the nucleotide addition processivity of telom-
erase, removes telomerase from telomere-like oligonucleo-
tides (Boulé et al. 2005), and unwinds the telomere–telom-
erase complex (Li et al. 2014). In vivo, mutation of PIF1 
causes telomere lengthening (Schulz and Zakian 1994) and 
increases telomere association of the telomerase subunits, 
Est1 and Est2 (Boulé et al. 2005; Phillips et al. 2015). On 
the other hand, Pif1 overexpression has been shown to cause 
telomere shortening (Zhou et al. 2000) and to reduce Est1 
Abstract Dysfunctional telomere length regulation is det-
rimental to human health, and both activation and inhibition 
of telomerase have been proposed in potential therapies to 
treat human diseases. The Saccharomyces cerevisiae Pif1 
protein is an evolutionarily conserved helicase that inhib-
its telomerase activity at DNA ends. Recent studies have 
indicated that Pif1 is specifically important for inhibiting 
telomerase at DNA ends with very little or no telomeric 
sequence and at long telomeres. At the former, Pif1 prevents 
the inappropriate addition of a telomere at DNA double-
strand breaks. For the latter, Pif1 has been shown to bind 
long telomeres to presumably promote the extension of the 
short ones. These observations leave the impression that 
Pif1 does not act at DNA ends with telomeric sequence of 
intermediate length. Here, we provide in vivo evidence that 
Pif1 inhibits telomerase activity at DNA ends regardless of 
telomere sequence length.
Keywords Pif1 · Telomeres · Telomerase · Telomere 
length homeostasis · Double-strand breaks
The ends of eukaryotic chromosomes are capped by tel-
omeres, nucleoprotein complexes that protect chromosome 
ends from degradation, and telomere–telomere fusion (Fer-
reira et al. 2004). Telomeres can shorten due to incomplete 
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and Est2 binding to chromosome ends (Boulé et al. 2005). 
Taken together, the evidence suggests that Pif1 regulates 
telomere length by unwinding the DNA–RNA hybrid formed 
by the telomeric DNA and telomerase RNA subunit.
Besides telomere length regulation, Pif1 function is also 
important at double-strand DNA breaks (DSBs). Gross chro-
mosomal rearrangements (GCR) are known to be increased 
230-fold in pif1-m2 cells, where only the nuclear function 
and not the mitochondrial function of Pif1 is affected (Schulz 
and Zakian 1994), and 1000-fold in pif1∆ cells (Myung et al. 
2001). The increase of GCR events in pif1-m2 cells is due 
to improper and deleterious addition of telomere sequence, 
and deletion of telomerase subunits rescues the GCR rate 
to wild-type levels (Myung et al. 2001). Pif1 is thought to 
prevent telomere sequence addition at DSBs in cooperation 
with Mec1-dependent inhibition of the single-stranded telo-
meric DNA-binding protein Cdc13, which is needed for the 
recruitment of telomerase (Nugent et al. 1996). In response 
to DNA damage, Cdc13 and Pif1 are phosphorylated in a 
Mec1-dependent manner to preserve genome stability. Phos-
phorylation of Cdc13 inhibits its accumulation at DSBs, thus 
preventing telomerase recruitment to these sites, and phos-
phorylated Pif1 removes telomerase from DSBs (Makovets 
and Blackburn 2009; Zhang and Durocher 2010).
Remarkably, although Pif1 functions both at DSBs and at 
telomeres, it is differently regulated at these two DNA ends. 
Two phosphorylation mutants of Pif1 support this idea: the 
unphosphorylatable pif1-4A mutant (T763A/S765A/S766A/
S769A) is unable to inhibit telomere addition at DSBs, but it 
does not result in bulk telomere lengthening at chromosome 
ends, whereas the pif1-4D mutant, which mimics consti-
tutive phosphorylation, restores Pif1 activity at DSBs but 
does not give rise to shorter telomeres. This observation 
implies that phosphorylation of Pif1 is important for inhibit-
ing telomerase at DSBs and not at telomeres (Makovets and 
Blackburn 2009).
In a recent study, Pif1 was reported to be found prefer-
entially at long telomeres, and it was suggested that this 
serves to promote telomerase-dependent extension of short 
telomeres (Phillips et al. 2015). We have also recently pub-
lished a study where the inducible HO cut system was used 
to create DNA ends adjacent to telomeric sequence of dif-
ferent length to monitor the ability of Pif1 to inhibit telom-
erase. We found that a 34-bp telomere tract is enough to 
render such an end insensitive to Pif1, resulting in a very 
high frequency of telomere addition. We defined this tract 
length as the DSB-telomere threshold, below which Pif1 
actively supresses telomere addition (Strecker et al. 2017). 
This result suggests that Pif1 activity becomes irrelevant at 
telomeres longer than 34 bp.
Together, the two above-mentioned studies give the 
impression that Pif1 activity is only relevant in two sce-
narios: (1) at DNA ends with no telomeric sequence or with 
telomeric sequence shorter than the DSB-telomere thresh-
old length, where its telomerase inhibitory activity protects 
genome stability by preventing inappropriate addition of 
telomeric sequences at DSBs, and (2) at long telomeres, 
where Pif1 inhibits telomerase to facilitate the extension of 
short telomeres. However, our data show that the telomer-
ase inhibitory activity of Pif1 takes place at all DNA ends, 
regardless of telomere length, and it is, therefore, telomere 
length independent.
We monitored telomerase-dependent telomere extension 
events in wild-type and pif1-m2 cells using the iSTEX assay, 
which allows us to detect telomere extension events at indi-
vidual telomeres at nucleotide resolution during a single cell 
cycle (Strecker et al. 2017). In wild-type cells, as previously 
reported, the frequency of telomere extension increases as 
telomere length decreases, and there is an increase in the 
extent of elongation at telomeres below 125 nt (Teixeira 
et al. 2004). In pif1-m2 cells, the extent of elongation at 
telomeres below 125 nt is even greater (Fig. 1a, b). Yeast 
telomerase is generally non-processive in terms of repeat 
addition, except at telomeres less than 125 nt in length, 
where an increase in repeat addition processivity leads to 
an increase in extension length (Chang et al. 2007). It is not 
known how this increased processivity is achieved, although 
it is known to be dependent on Tel1 (Chang et al. 2007), 
and we now propose that it is also inhibited by Pif1. The 
extent of elongation is not significantly different at telomeres 
greater than 125 nt in pif1-m2 cells, indicating that the lack 
of repeat addition processivity at such telomeres is not due 
to the presence of Pif1. Furthermore, we found an increase 
in the frequency of extension at telomeres of all length, but 
short telomeres were still preferentially extended (Fig. 2a, 
b). This implies that telomerase activity is inhibited by Pif1 
in a telomere length-independent fashion.
This finding is in agreement with a previous study show-
ing that the frequency and extent of elongation of telom-
eres between 50 and 200 nt in length was increased in pif1∆ 
cells (Phillips et al. 2015). The same study also reported 
increased Est1 and Est2 binding to an HO-induced  TG80 end, 
which mimics a short telomere, in pif1-m2 cells compared 
to the wild-type control. Intriguingly, Pif1 was also found 
to preferentially bind long telomeres (Phillips et al. 2015). 
If Pif1-mediated inhibition of telomerase is independent of 
telomere length, then why is Pif1 preferentially bound to 
long telomeres? Pif1 has several other functions in addi-
tion to telomerase inhibition. Pif1 is also known to function 
in Okazaki fragment processing (Budd et al. 2006) and to 
promote replication of hard-to-replicate sites, such as telom-
eres (Paeschke et al. 2011). Thus, the interpretation of Pif1 
binding to telomeres is complicated by the telomerase-inde-
pendent functions of Pif1 at telomeres. Longer telomeres 




A telomere length-independent regulation of telomer-
ase activity by Pif1 is also in conflict with the idea that 
Pif1 is active only below the DSB-telomere threshold to 
avoid telomere sequence addition at DSBs (Strecker et al. 
2017). However, the genetic assay to monitor telomere 
addition (which measures the ability of telomerase to add 
a telomere to a DNA end generated by the HO endonu-
clease, thereby allowing the cell to grow) might be less 
sensitive to detect Pif1 activity as compared to the iSTEX 
assay. While the iSTEX assay detects telomerase-mediated 
extension events during a 2-h window, the inducible HO 
method allows a much longer time for a telomere addition 
event to occur: telomere addition can take place at any 
time during the 4-h growth period in galactose-containing 
medium to induce the HO cut, and within a few hours 
after plating, which would still give enough time for a 
Fig. 1  Mutation of PIF1 increases telomere extension length at tel-
omeres less than 125 nt in length. Length of telomere extension for 
telomeres V-R (a) and VI-R (b), obtained from iSTEX analysis of 
wild-type and pif1-m2 cells (Strecker et al. 2017), is plotted accord-
ing to telomere length prior to telomerase induction (< 125 and ≥ 125 
nt). Statistical significance was determined using a two-tailed Mann–
Whitney U test. *p value < 0.00001 and ns not significant
Fig. 2  Mutation of PIF1 increases the frequency of telomere exten-
sion. Telomere V-R (a) and telomere VI-R (b) sequences obtained 
from the iSTEX analysis of wild-type and pif1-m2 cells (Strecker 
et  al. 2017) were binned into groups of 10 nt in size according 
to telomere length before telomerase induction. Groups contain-
ing less than five telomeres were excluded from this analysis. Fre-
quency of extension and average telomere length before telomerase 
induction were calculated and plotted for each group. Logarithmic 
regression curves for each data set were determined using Micro-
soft Excel. The equations of the curves for telomere V-R are 
y = −  46.06ln(x) + 237.61 (wild-type) and y = − 40.13ln(x) + 227.05 
(pif1-m2). The equations of the curves for telomere VI-R are 
y = − 39.89ln(x) + 206.47 (wild-type) and y = − 46ln(x) + 259.99 (pif1-
m2). R2 indicates coefficient of determination. Telomeres shorter than 
40 nt before telomerase induction, below the DSB-telomere threshold 
(dashed line), were excluded from the regression analysis
 Curr Genet
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cell to add a telomere to the DSB and form a colony at the 
end of the 3-day experiment. Therefore, telomere addi-
tion frequency in the inducible HO cut method is already 
very high at a DNA end adjacent to telomeric sequence 
above the DSB-telomere threshold (~ 90% at a DNA end 
with 34 bp of telomeric sequence; Strecker et al. 2017), 
making a further increase in frequency undetectable upon 
mutation of PIF1.
In summary, we have found that Pif1 inhibits telomer-
ase in a similar way across all telomere lengths, indicating 
that its function on telomerase inhibition does not depend 
on telomere length. However, several questions remain 
unanswered. How does phosphorylation of Pif1 only 
affect its activity at DNA ends below the DSB-telomere 
threshold? If Pif1 is acting on both sides of this thresh-
old, how is the threshold set? As we previously proposed 
(Strecker et al. 2017), a DNA end below the DSB-telomere 
threshold is unable to efficiently recruit or activate telom-
erase for a still unclear reason, and Pif1 activity ensures 
that telomerase is tightly inhibited. Above the threshold, 
telomerase recruitment/activation is strong, making Pif1 
largely irrelevant. The difference above and below the 
threshold is independent of the interaction between Cdc13 
and telomerase (Strecker et al. 2017), so, perhaps, it is 
recruitment of Cdc13 itself that is important. Furthermore, 
characterizing the role of Pif1 in telomerase inhibition is 
complicated by the telomerase-independent functions of 
Pif1, which could indirectly affect telomerase activity. 
Most of its telomerase-independent functions—Okazaki 
fragment processing, DNA end resection, break-induced 
replication, G-quadruplex unwinding, and destabilization 
of R-loops—are either known to or have been proposed 
to occur at telomeres as well (Dewar and Lydall 2010; 
Geronimo and Zakian 2016). Further work will be required 
to characterize what role Pif1 plays in each of these pro-
cesses at telomeres.
Pif1 helicases are highly conserved and its family mem-
bers are identified from bacteria to humans (Bochman 
et al. 2010). Human Pif1, which has 24% sequence identify 
to Pif1 in S. cerevisiae (Bochman et al. 2010), was shown 
to bind to telomeric sequences in vitro (Zhang et al. 2006) 
and to interact with the catalytic subunit of telomerase 
(Mateyak and Zakian 2006). These observations, together 
with the fact that telomerase is upregulated in ~ 90% of 
human cancers (Hanahan and Weinberg 2011), make Pif1 
and its associated proteins possible targets for future thera-
pies involving the alteration of telomerase activity.
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